Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Genetic testing and implications in early breast cancer (eBC) patients

Surgical options for BRCA mutated eBC patients

Date

04 May 2022

Session

Genetic testing and implications in early breast cancer (eBC) patients

Topics

Tumour Site

Breast Cancer

Presenters

Maria Joao Cardoso

Authors

M. Joao Cardoso

Author affiliations

Fundacao Champalimaud, Lisbon/PT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

04 May 2022

Neo/adjuvant PARP inhibitors

Presenter: Andrew Tutt

Session: Genetic testing and implications in early breast cancer (eBC) patients

Resources:

Slides

Webcast

04 May 2022

Who and how to test for BRCA mutations

Presenter: Christian Singer

Session: Genetic testing and implications in early breast cancer (eBC) patients

Resources:

Slides

Webcast

04 May 2022

Best additional systemic treatment options for eBC in the era of PARP inhibitors

Presenter: Sabine Linn

Session: Genetic testing and implications in early breast cancer (eBC) patients

Resources:

Slides

Webcast

04 May 2022

Q&A

Presenter: All Speakers

Session: Genetic testing and implications in early breast cancer (eBC) patients

Resources:

Webcast